检索结果 - Eric Bleickardt

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis

    Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis 由 Neil P. Shah, Corynn Kasap, Christopher Weier, Minna Balbas, John Nicoll, Eric Bleickardt, Claude Nicaise, Charles L. Sawyers

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia

    Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia 由 Alfonso Quintás-Cardama, Jorge E. Cortés, Susan O’Brien, Farhad Ravandi, Gautam Borthakur, David Liu, Eric Bleickardt, Tai‐Tsang Chen, Hagop M. Kantarjian

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Dasatinib or high‐dose imatinib for chronic‐phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily

    Dasatinib or high‐dose imatinib for chronic‐phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily 由 Hagop M. Kantarjian, Ricardo Pasqüini, Vincent Lévy, Saengsuree Jootar, Jerzy Hołowiecki, Nelson Hamerschlak, Timothy P. Hughes, Eric Bleickardt, David Dejardin, Jorge E. Cortés, Neil P. Shah

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study

    Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase... 由 Jesús G. Berdeja, Sundar Jagannath, Jeffrey A. Zonder, Ashraf Badros, Jonathan L. Kaufman, Robert Manges, Manish Gupta, Amol Tendolkar, Mark Lynch, Eric Bleickardt, Prashni Paliwal, Ravi Vij

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Elotuzumab in combination with thalidomide and low‐dose dexamethasone: a phase 2 single‐arm safety study in patients with relapsed/refractory multiple myeloma

    Elotuzumab in combination with thalidomide and low‐dose dexamethasone: a phase 2 single‐arm safety study in patients with relapsed/refractory multiple myeloma 由 María‐Victoria Mateos, Miguel Granell, Albert Oriol, Joaquín Martínez‐López, Joan Bladé, Miguel‐Teodoro Hernández, Jesús Martín, Mercedes Gironella, Mark Lynch, Eric Bleickardt, Prashni Paliwal, Anil Singhal, Jesús F. San Miguel

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-escalation study

    Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-esc... 由 Paul G. Richardson, Sundar Jagannath, Philippe Moreau, Andrzej Jakubowiak, Marc S. Raab, Thierry Façon, Ravi Vij, Darrell White, Donna Reece, Lotfi Benboubker, Jeffrey A. Zonder, L. Claire Tsao, Kenneth C. Anderson, Eric Bleickardt, Anil Singhal, Sagar Lonial

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM

    Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM 由 Andrzej Jakubowiak, Massimo Offidani, Brigitte Pegourié, Javier de la Rubia, Laurent Garderet, Kamel Laribi, Alberto Bosi, Roberto Marasca, Jacob P. Laubach, Ann Mohrbacher, Angelo Michele Carella, Anil Singhal, L. Claire Tsao, Mark Lynch, Eric Bleickardt, Ying‐Ming Jou, Michael Robbins, Antonio Palumbo

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

    Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias 由 Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian, Nicholas J. Donato, John Nicoll, Ron Paquette, Jorge E. Cortés, Susan O’Brien, Claude Nicaise, Eric Bleickardt, M. Anne Blackwood-Chirchir, Vishwanath R. Iyer, Tai‐Tsang Chen, Fei Huang, Arthur P. DeCillis, Charles L. Sawyers

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

    Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia 由 Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus, Jorge E. Cortés, Sandip Shah, Manuel Ayala, Beatriz Moiraghi, Zhi-Xiang Shen, Jiřı́ Mayer, Ricardo Pasqüini, Hirohisa Nakamae, Françoise Huguet, Concepción Boqué, Charles Chuah, Eric Bleickardt, M. Brigid Bradley‐Garelik, Chao Zhu, Ted P. Szatrowski, Д. А. Шапиро, Michele Baccarani

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia

    Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leu... 由 Neil P. Shah, Hagop M. Kantarjian, Dong‐Wook Kim, Delphine Réa, Pedro Enrique Dorlhiac‐Llacer, Jorge Milone, Jorge Vela‐Ojeda, Richard T. Silver, H. Jean Khoury, Aude Charbonnier, Н Д Хорошко, Ronald Paquette, Michael W. Deininger, Robert H. Collins, I. Rodríguez-M. Otero, Timothy P. Hughes, Eric Bleickardt, Lewis C. Strauss, Stephen Francis, Andreas Hochhaus

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: <scp>ELOQUENT</scp>‐2 follow‐up and <i>post‐hoc</i> analyses on progression‐free survival and tumour growth

    Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: <scp>ELOQUENT</scp>‐2 follow‐up and <i>post‐hoc</i> analyses on progression‐free survival an... 由 Meletios Α. Dimopoulos, Sagar Lonial, Darrell White, Philippe Moreau, Antonio Palumbo, Jesús F. San Miguel, Ofer Shpilberg, Kenneth C. Anderson, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Hila Magen, María‐Victoria Mateos, Andrew R. Belch, Donna Reece, Meral Beksaç, Eric Bleickardt, Valerie Poulart, Jennifer Sheng, Oumar Sy, Jessica Katz, Anil Singhal, Paul G. Richardson

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma 由 Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Philippe Moreau, María‐Victoria Mateos, Hila Magen, Andrew R. Belch, Donna Reece, Meral Beksaç, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Ka Lung Wu, Anil Singhal, Jesús F. San Miguel, Morio Matsumoto, Jessica Katz, Eric Bleickardt, Valerie Poulart, Kenneth C. Anderson, Paul G. Richardson

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial

    Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial 由 Stephan A. Grupp, Shannon L. Maude, Susana Rives, André Baruchel, Michael Boyer, Henrique Bittencourt, Peter Bader, Jochen Büchner, Theodore W. Laetsch, Heather E. Stefanski, Gary Douglas Myers, Muna Qayed, Michael A. Pulsipher, Barbara De Moerloose, Gregory A. Yanik, Kara L. Davis, Paul L. Martin, Eneida R. Nemecek, Christina Peters, Joerg Krueger, Adriana Balduzzi, Nicolas Boissel, Françoise Méchinaud, Mimi Leung, Lamis Eldjerou, Eric Bleickardt, Karen Thudium Mueller, Hidefumi Hiramatsu

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

    Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma 由 Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran, Theodore W. Laetsch, Frederick L. Locke, Rayne H. Rouce, Michael A. Pulsipher, Christine L. Phillips, Amy K. Keating, Matthew J. Frigault, Dana Salzberg, Samantha Jaglowski, Joshua Sasine, Joseph Rosenthal, Monalisa Ghosh, Daniel J. Landsburg, Steven Margossian, Paul L. Martin, Manali Kamdar, Peiman Hematti, Sarah Nikiforow, Cameron J. Turtle, Miguel‐Angel Perales, Patricia Steinert, Mary M. Horowitz, Amy Moskop, Lida Pacaud, Lan Yi, Raghav Chawla, Eric Bleickardt, Stephan A. Grupp

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    2019 ASPHO ABSTRACTS

    2019 ASPHO ABSTRACTS 由 Michael A. Pulsipher, Xia Han, Máire F. Quigley, Gabor Kari, Susana Rives, Theodore W. Laetsch, Gary Douglas Myers, Hidefumi Hiramatsu, Gregory A. Yanik, Muna Qayed, Timothy Driscoll, Michael Boyer, Heather E. Stefanski, Jochen Büchner, André Baruchel, Peter Bader, Lan Yi, Creton Kalfoglou, Harlan Robins, Erik Yusko, Güllü Görgün, Eric Bleickardt, Stephane Wong, Stephan A. Grupp, Timothy S. Olson, Mark C. Walters, Janet Kwiatkowski, Suradej Hongeng, John E.J. Rasko, John B. Porter, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Gary J. Schiller, Heidi Elliot, Briana Deary, Ying Chen, Ge Tao, Mohammed Asmal, Franco Locatelli, Alexis A. Thompson, Loretta S. Li, Shannon Harkins, Kristen E. Stevenson, Sayalee Potdar, Praveen Anand, Olivia D. Plana, Catharine Leahy, Birgit Knoechel, David M. Weinstock, Akshay Sharma, Yu Yao, Jiyang Yu, Yong‐Dong Wang, Shengdar Q. Tsai, Kaitly J. Woodard, Mitchell J. Weiss, Carl E. Allen, Michael B. Jordan, Simone Cesaro, Carmelo Rizzari, Anupama Rao, Timothy Garrington, Julián Sevilla, Maria Caterina Putti, Franca Fagioli, Martina Ahlmann, Jose-Luis Dapena, Alexei A. Grom, Fabrizio De Benedetti, Walter Ferlin, Maria Ballabio, Cristina de Min

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: